Navigation Links
Bayer Appoints Bhavesh Ashar to Lead U.S. Oncology Business
Date:5/2/2017

WHIPPANY, N.J., May 2, 2017 /PRNewswire/ -- Bayer today announced the appointment of Bhavesh Ashar as senior vice president and head of Oncology for the company's Pharmaceuticals Division in the United States. Ashar will report to Carsten Brunn, Head of Bayer Pharmaceuticals for the Americas region.

"Bhavesh is a well-respected, results-driven leader with extensive industry knowledge and a proven track record of launching products and driving growth in oncology," said Brunn. "We are delighted to have Bhavesh join Bayer's U.S. Pharmaceuticals organization. I'm confident that he will help to advance our growing leadership in oncology and our ongoing commitment to meeting the needs of people living with cancer."

Previously, Ashar served as vice president and general manager of U.S. Oncology at Sanofi and was responsible for managing a diverse portfolio comprising solid tumor, hematology and transplant products. Ashar was with Sanofi for more than 14 years and held positions of increasing responsibility in sales and marketing, with a strong focus on specialty markets. Prior to joining Sanofi, Ashar served as an engagement manager with McKinsey & Company.

Bayer's diverse oncology portfolio and pipeline is helping to address some of the most difficult to treat cancers in areas of high unmet need. The oncology franchise includes three marketed products and several other compounds in various stages of clinical development.

"Oncology is a critical growth driver for Bayer and I am excited to help the company realize the full potential of its diverse cancer portfolio," said Ashar.

Ashar holds a Bachelor of Science degree in Mathematics from Imperial College in London and an MBA from the University of Chicago Booth School of Business.

Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.us.

© 2017 Bayer

Forward-Looking Statement
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Intended for U.S. Media Only

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bayer-appoints-bhavesh-ashar-to-lead-us-oncology-business-300449550.html


'/>"/>
SOURCE Bayer
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
2. Statement: Bayer Mourns Passing of Senator Frank Lautenberg
3. FDA Advisory Committee Unanimously Recommends Approval Of Bayers Riociguat In Two Pulmonary Hypertension Indications
4. Among the Novel Oral Anticoagulants, Bayer/Janssens Xarelto is Positioned To Be the Sales-Leading Therapy for Venous Thromboembolism (VTE)
5. Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy
6. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
7. Bayer HealthCare Awards Veterinary Students $72,500 in Scholarship Funds for Communications Excellence
8. Bayers Third Annual Virtual Walk for Hemophilia Raises Funds, Brings Together the Hemophilia Community
9. Bayer HealthCare Announces Collaboration with the University of Texas MD Anderson Cancer Center
10. Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration
11. Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... DUBLIN , Aug. 7, 2017  Endo International ... has reached agreements to resolve virtually all known U.S. ... in discussions to resolve the known remaining U.S. claims ... installment payments beginning in the fourth quarter of 2017 ... part of its second quarter 2017 results, the Company ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:7/31/2017)... 2017 Three Tru-D SmartUVC robots have arrived at ... . Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 ... environmental services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at ... "Although the BAACH has a very low ...
Breaking Medicine Technology:
(Date:8/19/2017)... ... August 19, 2017 , ... Curl Keeper® is excited to announce that ... Editors’ Choice 2017 Award for the second year in a row. The H2O Bottle, ... alike was voted Best Moisturizer for Type 2 Wavies and Best Refresher for Type ...
(Date:8/19/2017)... ... ... It's A Boy! God’s Gift: A Story of Love”: a children’s book that shows ... God’s Gift: A Story of Love” is the creation of published authors, Dale Anthony ... Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect gift for ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today ... for active, healthy lifestyles and highlighting the importance of proactive eye and ear ... and shares the latest innovations in hearing aid technology. , In this ...
(Date:8/18/2017)... ... 18, 2017 , ... Hernandez Insurance Agencies, a northern Virginia ... greater DC region, is inaugurating a “New Leash On Life” charity initiative in ... them to be companions for veterans in need. , The Semper K9 organization ...
(Date:8/18/2017)... ... 2017 , ... Goss & Associates Insurance Agency, a family ... in the greater Houston region, is helping locally recognized nonprofit Addi’s Faith Foundation ... , Founded by Tony and Amber Bender after losing their young daughter Addison ...
Breaking Medicine News(10 mins):